Use of epinephrine for IFIS prophylaxis.
Shugar
Joel K
JK
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects; D000867:Anterior Chamber / Q000187:drug effects; D002387:Cataract Extraction; D004837:Epinephrine / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007499:Iris Diseases / Q000139:chemically induced / Q000517:prevention & control*; D008297:Male; D009184:Mydriatics / Q000737:chemistry / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000188:drug therapy; D011680:Pupil / Q000187:drug effects*; D013449:Sulfonamides / Q000009:adverse effects; D013577:Syndrome; D000077409:Tamsulosin
D000317:Adrenergic alpha-Antagonists; D009184:Mydriatics; D013449:Sulfonamides; D000077409:Tamsulosin; D004837:Epinephrine